Vistin Pharma ASA (OSL:VISTN)
Norway · Delayed Price · Currency is NOK 20.50
-0.20 (-0.97%)
At close: Jun 3, 2026
Vistin Pharma ASA Market Cap
Vistin Pharma ASA has a market cap or net worth of 909.06 million as of June 3, 2026. Its market cap has decreased by -17.34% in one year.
Market Cap
909.06M
Enterprise Value
903.24M
Revenue
449.47M
Ranking
n/a
PE Ratio
12.20
Stock Price
20.50
Market Cap Chart
Since June 10, 2015, Vistin Pharma ASA's market cap has increased from 322.34M to 909.06M, an increase of 182.02%. That is a compound annual growth rate of 9.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 909.06M | -1.44% |
| Dec 30, 2025 | 922.37M | -12.24% |
| Dec 30, 2024 | 1.05B | 1.72% |
| Dec 29, 2023 | 1.03B | 47.47% |
| Dec 30, 2022 | 700.64M | -18.47% |
| Dec 30, 2021 | 859.40M | 11.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.17B |
| Nordhealth AS | 2.16B |
| Circio Holding ASA | 2.14B |
| Thor Medical ASA | 1.68B |
| ArcticZymes Technologies ASA | 1.15B |
| Nykode Therapeutics AS | 1.02B |
| Lytix Biopharma ASA | 811.30M |
| Omda AS | 723.92M |